Printer Friendly

BIO-VASCULAR NAMES AFRYL AS VICE PRESIDENT-SALES AND MARKETING

 BIO-VASCULAR NAMES AFRYL AS VICE PRESIDENT-SALES AND MARKETING
 ST. PAUL, Minn., July 14 /PRNewswire/ -- Bio-Vascular, Inc. (NASDAQ: BVAS) today announced the appointment of Joseph J. Afryl, Jr., as vice president of sales and marketing.
 Afryl brings to Bio-Vascular 15 years of experience in cardiovascular sales and most recently served as director of sales for Angeion Corporation. He spent four years as director of marketing for St. Jude Medical, Inc., and four years as director of sales and marketing for the Asia/Pacific Division of Bard International, Inc. He began his sales and marketing career with USCI (then the vascular graft division of Bard) as a sales representative in 1977 and later became a senior product manager for USCI International, Inc.
 Afryl is a graduate of Florida State University. He lives in North Oaks, Minn., a suburb of St. Paul.
 Bio-Vascular, Inc., based in St. Paul, is a manufacturer and marketer of proprietary consumable medical products for cardiac and vascular surgery.
 -0- 7/14/92
 /CONTACT: Curt Swenson of Swenson Falker Eilertsen, 612-371-0000; or John H. Darnall or Karen Gilles of Bio-Vascular, 612-631-3529/
 (BVAS) CO: Bio-Vascular, Inc. ST: Minnesota IN: MTC SU: PER


KH -- MN008 -- 9148 07/14/92 13:18 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 14, 1992
Words:201
Previous Article:HUGHES SUPPLY DECLARES REGULAR QUARTERLY CASH DIVIDEND OF $.03 PER SHARE
Next Article:MCI ANNOUNCES EXECUTIVE CHANGES IN REALIGNMENT OF BUSINESS MARKET UNITS
Topics:


Related Articles
BIO-VASCULAR NAMES SCHANKERELI DIRECTOR OF RESEARCH AND DEVELOPMENT
DARNALL RESIGNS AS BIO-VASCULAR CHIEF EXECUTIVE; THREE EXECUTIVES TO FORM NEW OFFICE OF PRESIDENT
BIO-VASCULAR PICKS LYONS AS CHIEF EXECUTIVE OFFICER
BIO-VASCULAR NAMES KEMAL SHANKERELI VICE PRESIDENT OF RESEARCH AND DEVELOPMENT
BIO-VASCULAR NAMES KARCANES AS PRESIDENT AND CHIEF OPERATING OFFICER
JOSEPH J. AFRYL JR. JOINS POSSIS MEDICAL, INC. AS VICE PRESIDENT OF SALES AND MARKETING
BIO-VASCULAR ELECTS PERLMAN TO BOARD OF DIRECTORS
BIO-VASCULAR STRENGTHENS MANAGEMENT TEAM WITH STEPHENSON APPOINTMENT
BIO-VASCULAR NAMES WEISS TO HEAD VITAL IMAGES SUBSIDIARY
M. Karen Gilles Named CEO of Bio-Vascular, Succeeding John Karcanes Who Has Resigned

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters